🛌 Recovery Facts

Bosquet et al. 2013 (PMID 23435903) showed active tapering preserves 97% of performance vs 91% for complete rest. CNS recovery rates are comparable between protocols at 5-7 days.

Fixed 4-week deload cycles are not supported by evidence. RPE-based autoregulation (Zourdos et al. 2016) and HRV-guided periodization outperform fixed schedules by reducing false positives and unnecessary recovery weeks.

Volume deloads cut sets by 40-60% and clear fatigue within 5-7 days; intensity deloads at 60-70% 1RM preserve neuromuscular drive while allowing metabolic recovery.

Deload volume cuts of 40-60% over 5-7 days preserve 95-100% of strength when intensity stays above 80% 1RM. Issurin 2010 and Murach & Bagley 2015 (PMID 26284291) establish phase-specific volume targets.

Issurin & Lustig 2004 and Murach & Bagley 2015 (PMID 26284291) show 3-5 day mini-deloads clear acute fatigue effectively while full 7-day deloads are required after 4-6 week accumulation phases.

The supercompensation window peaks at days 5-10 post-deload with estimated 2-8% performance capacity above baseline. Meeusen et al. 2013 (DOI 10.1080/17461391.2012.730061) and Zatsiorsky & Kraemer provide the foundational framework.

Lower body first, upper body second on consecutive days is supported by glycogen recovery data; 6-hour inter-session gaps allow partial glycogen resynthesis (~50% restoration) when carbohydrates are consumed immediately (Duthie et al., 2003 — PMID 14565765).

Detraining of strength begins within 2–3 weeks of inactivity; maintaining 1/3 of training frequency preserves most gains during in-season phases (Mujika & Padilla, 2000 — PMID 10870179).

Masters athletes (40+) show MPS elevation lasting 48–72 hours vs. 24–36 hours in younger adults, requiring adjusted training frequency and longer inter-session recovery gaps (Deane et al., 2019 — PMID 30586792).

CK above 1000 U/L post-session indicates significant muscle damage; T:C ratio below 0.35 signals inadequate anabolic drive. Both predict overreaching when sustained (Koch et al., 2014 — PMID 24424516).

A >3% drop in CMJ height and >5% drop in grip strength signal meaningful neuromuscular fatigue; both outperform subjective ratings alone (Cormack et al., 2008).

Whoop, Garmin, and Oura use HRV-anchored algorithms with 24-hour update cycles; Düking et al. 2018 found low-to-moderate agreement between wearable readiness scores and gold-standard lab markers.

Foster's sRPE model (2001): session load = RPE (6-20 Borg) × duration in minutes; weekly monotony = mean load / SD; strain = total load × monotony. Monotony >2.0 signals overreaching risk.

The 7-item Hooper Index detected overreaching 3–5 days earlier than blood markers in 24 collegiate swimmers; REST-Q-76 validity for mood disturbance r=0.72 (Hooper et al., 1995).

Burke et al. 2011 (PMID 21816732) and Yeo et al. 2008 (PMID 18073197) show periodized CHO (5-8g/kg on hard days, 2-3g/kg on easy days) enhances metabolic enzyme adaptation compared to uniformly high CHO intake.

Creatine loading (20 g/day for 5 days) accelerates recovery from eccentric damage by 10-15% and reduces CK elevation; satellite cell activation is a primary repair mechanism.

A 2% body weight deficit reduces endurance capacity by 10-20% and impairs cognitive performance; sweat rates average 0.5-2.0 L/hour depending on intensity and heat.

Aragon & Schoenfeld 2013 (PMID 23360586) found the anabolic window extends to 2 hours post-exercise. Protein at 0.4g/kg and carbs at 0.8g/kg within that window optimize glycogen resynthesis and MPS simultaneously.

Moore et al. 2012 (PMID 22313809) showed 4x daily protein doses outperform 2x or 8x for MPS. Each dose requires 2.5-3g leucine (Areta et al. 2013, PMID 23459753) to maximally activate mTORC1 signaling.

Howatson et al. 2010 (PMID 19883392) showed 480mg anthocyanins twice daily reduced DOMS by 20% and accelerated strength recovery. Bell et al. 2014 (PMID 24791928) confirmed effects in strength athletes over 10 days.

Gandevia 2001 demonstrated voluntary activation failure reduces force output by up to 20-30% during sustained maximal effort, independent of peripheral contractile failure (PMID 11152758).

Shaw et al. 2017 showed collagen synthesis in tendons peaks at 72-96 hours post-exercise and that 15g collagen + vitamin C pre-exercise doubled collagen synthesis markers; Kjaer 2004 confirmed tendon protein turnover rate is 3-5x slower than muscle (PMID 15102804).

Ivy 1998 demonstrated a 45-minute post-exercise window of accelerated glycogen resynthesis at 7-10 mmol/kg/hr; Jentjens & Jeukendrup 2003 showed CHO+PRO ingestion increases synthesis rate by ~38% versus CHO alone at matched energy intake.

Tidball 2011 established that neutrophil and macrophage infiltration within 6-24 hours of muscle damage is required for satellite cell activation and full myofiber repair; indiscriminate NSAID use blunts this response (PMID 21454742).

Biolo et al. 1995 measured a 3-fold increase in MPS within 3 hours of resistance exercise with adequate amino acid provision; Moore et al. 2009 found MPS returns near baseline by 28 hours in trained men (PMID 7572124).

Meeusen et al. 2013 consensus defined two stages of overreaching — functional (2-week recovery) and non-functional (weeks to months) — driven by stimulus application before SRA completion; Zatsiorsky & Kraemer quantified SRA timelines across athlete levels.

Meta-analysis of 23 studies: compression garments reduce DOMS by d=0.42 and improve perceived recovery by d=0.52; 15-30 mmHg is the effective pressure range for post-exercise use.

Meta-analysis shows CWT reduces DOMS vs. passive rest (d=0.54) but is not superior to cold-only immersion; optimal cycles are 3-4 alternations with 1-minute cold at 10-15°C.

Meta-analysis of 14 studies: foam rolling reduces DOMS by ~3-5 points on 100mm VAS and improves ROM by ~10%; the mechanism is neurological gate inhibition, not tissue release.

Meta-analysis of 22 RCTs: massage reduces DOMS by ~30% at 48-72h (d=0.92) and anxiety by 0.75; 15-20 minute sessions show similar benefit to longer ones.

Regular sauna use (80-100°C, 20 min, 2-3x/week) increases plasma volume by 3-5%, upregulates HSP70, and reduces CK by ~15% after 3 weeks of consistent exposure.

Cochrane review (Herbert et al. 2011, 12 trials): stretching before or after exercise reduces DOMS by less than 2mm on a 100mm VAS — not clinically significant. Injury prevention: no effect.

Functional overreaching produces a performance decrement that fully reverses within 7–14 days; deliberate FO followed by structured taper can yield 3–8% performance gains (Halson & Jeukendrup, 2004 — PMID 15335243).

NFO requires 4–12 weeks of reduced training for full recovery; T:C ratio below 0.35 for two or more consecutive weeks is a primary diagnostic marker (Meeusen et al., 2013 — DOI 10.1080/17461391.2012.730061).

OTS affects approximately 10% of athletes presenting with NFO; recovery takes months to over a year and requires full cessation of structured training — not just reduction (Meeusen et al., 2013 — DOI 10.1080/17461391.2012.730061).

The ABQ measures exhaustion, devaluation, and reduced accomplishment across 15 items; burnout is distinct from OTS — HRV may be normal while motivation is profoundly lost (Raedeke & Smith, 2001 — PMID 11547920).

HRV drops 5-7 days before measurable performance decline in functional overreaching; non-functional overreaching suppresses resting RMSSD for 4-12 weeks requiring extended recovery.

Kiviniemi et al. 2007 showed HRV-guided training improved VO2max by 9.5% versus 7.2% for fixed periodization over 4 weeks; Plews et al. 2013 documented that sustained RMSSD 8% below rolling mean predicted overreaching in elite triathletes (PMID 17618922).

Poor sleep reduces next-morning RMSSD by 8-15%; a single night of fragmented sleep suppresses resting HRV comparably to a hard 90-minute training session.

Resonance frequency breathing at 5.5 breaths/min for 20 minutes daily increases resting RMSSD by 10-20% after 8 weeks; baroreflex sensitivity gains persist without active practice.

Buchheit 2014 established RMSSD as the preferred HRV metric for athlete monitoring due to its parasympathetic specificity and low measurement noise; Task Force 1996 defined HRV frequency domains still used as standards today (PMID 24458556, PMID 8737210).

Wallén et al. 2012 found wrist PPG sensors showed RMSSD errors of 3-8 ms vs chest ECG under resting conditions; Plews et al. 2017 demonstrated that ultra-short 1-minute recordings correlate at r=0.97 with 5-minute standards when properly standardized.

Nunan et al. 2010 meta-analysis of 44 studies established RMSSD mean of 42 ms (SD 15 ms) in healthy adults; Sammito & Böckelmann 2016 confirmed male RMSSD declines approximately 1 ms per decade from age 20 onward (PMID 20561700).

Single HRV readings carry 12-18% coefficient of variation in athletes; a 7-day rolling average reduces false alarms from ~35% to under 10%, requiring minimum 14 days of baseline data.

A 26-minute NASA nap improved alertness by 54% and performance by 34% in pilots; 90-minute naps capturing SWS restore cognitive performance to rested baseline after 24 hours of sleep deprivation.

Sprint speed declines 1-3% per night of sleep restriction; reaction time increases 14% at 24-hour deprivation; endurance drops 11% after 30 hours awake — all reversible with 2 nights of recovery sleep.

After 14 days at 6 hours nightly, performance deficits match two nights of total deprivation; 2-3 recovery nights restore alertness but not full cognitive function — full recovery requires equivalent duration of adequate sleep.

Basketball players sleeping 10 hours nightly for 5-7 weeks improved sprint speed by 0.7 seconds, free throw accuracy by 9%, and 3-point shooting by 9.2% — all without other training changes (Mah et al., 2011, PMID 21731144).

Consumer trackers detect total sleep/wake at 80-95% accuracy vs PSG, but sleep stage accuracy falls to 50-70%; SWS (slow-wave sleep) detection is the weakest metric across all devices tested.

Eastward jet lag requires ~1.5 days per time zone to adapt vs ~1 day westward; 0.5mg melatonin taken 3-5 hours before target bedtime accelerates circadian adaptation by 30-50%.